Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siwalik Banerjee

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Plos One|February 14, 2015
Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/AIDS in a poor resource setting: observation from IndiaAvirup Chakraborty, Tanmay Mahapatra, Sanchita Mahapatra, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|July 23, 2025
IL17 in Sarcoidosis - A level playing field?Deepak Nagra, Hassan Choudry, Joy Odia, et al.
Rheumatology (Oxford, England)|July 15, 2021
Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: key points to prevent misdiagnosisItalo Marago, Mark Roberts, Federico Roncaroli, et al.
Mediterranean Journal of Rheumatology|May 8, 2026
Giant Cell Myocarditis: Is It Time to Redeploy Cytokine Inhibitors?Deepak Nagra, Iyantha Sarindhi Kuruppurachchi, Kaiyang Song, et al.
Frontiers in Immunology|April 1, 2026
The role of interleukin-17 inhibition in systemic lupus erythematosus-paradoxical hindrance or new therapeutic potential? Results from a systematic literature review and mendelian randomizationDeepak Nagra, Benjamin Zuckerman, Joy Odia, et al.
Rheumatology (Oxford, England)|June 30, 2025
The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors- a review of the literatureDeepak Nagra, Kaiyang Song, Joy Odia, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Plos One|February 14, 2015
Distribution and determinants of cytomegalovirus induced end organ disease/s among people living with HIV/AIDS in a poor resource setting: observation from IndiaAvirup Chakraborty, Tanmay Mahapatra, Sanchita Mahapatra, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|July 23, 2025
IL17 in Sarcoidosis - A level playing field?Deepak Nagra, Hassan Choudry, Joy Odia, et al.
Rheumatology (Oxford, England)|July 15, 2021
Limb girdle muscular dystrophy R12 (LGMD 2L, anoctaminopathy) mimicking idiopathic inflammatory myopathy: key points to prevent misdiagnosisItalo Marago, Mark Roberts, Federico Roncaroli, et al.
Mediterranean Journal of Rheumatology|May 8, 2026
Giant Cell Myocarditis: Is It Time to Redeploy Cytokine Inhibitors?Deepak Nagra, Iyantha Sarindhi Kuruppurachchi, Kaiyang Song, et al.
Frontiers in Immunology|April 1, 2026
The role of interleukin-17 inhibition in systemic lupus erythematosus-paradoxical hindrance or new therapeutic potential? Results from a systematic literature review and mendelian randomizationDeepak Nagra, Benjamin Zuckerman, Joy Odia, et al.
Rheumatology (Oxford, England)|June 30, 2025
The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors- a review of the literatureDeepak Nagra, Kaiyang Song, Joy Odia, et al.
Pageof 2